Unichem Laboratories stock zooms 3% after receiving USFDA nod for Nebivolol Tablets

16 Mar 2022 , 12:57 PM

Unichem Laboratories Limited stocks rallied in the bullish market on Wednesday as the pharma-major has received ANDA approval for its Nebivolol Tablets 2.5 mg, 5 mg, 10 mg, and 20 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Bystolic (nebivolol) Tablets 2.5 mg, 5 mg, 10 mg, and 20 mg, of Allergan Sales, LLC.

As per regulatory filing, Nebivolol Tablets are indicated for the treatment of hypertension. The product will be commercialized from Unichem’s Ghaziabad Plant.

At around 1:00 PM, Unichem Laboratories was trading at Rs252.65 apiece up by Rs7.2 or 2.93% on Sensex.